Indian Council of Medical Research (ICMR)

COVAXIN Phase-III Results; Demonstrates Clinical Efficacy of 78%, 100% efficacy against Severe COVID-19 disease

Bharat Biotech, an Indian origin global leader in vaccine innovation, developing vaccines for infectious diseases, announced…

DIHAR: DRDO has established a COVID-19 testing facility at the Leh based laboratory Defence Institute of…